SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-022106
Filing Date
2021-04-19
Accepted
2021-04-19 16:30:30
Documents
2
Period of Report
2021-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea139574-8k_virpaxpharma.htm 8-K 23442
2 GUDIN EMPLOYMENT AGREEMENT ea139574ex10-1_virpaxpharma.htm EX-10.1 58463
  Complete submission text file 0001213900-21-022106.txt   83212
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 21834980
SIC: 2834 Pharmaceutical Preparations